Source:http://linkedlifedata.com/resource/pubmed/id/14993200
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2004-5-6
|
| pubmed:abstractText |
Aldosterone has long been known to control water and electrolyte balance by acting on mineralocorticoid receptors in kidney. However, recent studies demonstrated the presence of these receptors in nonclassical locations, including the cardiovascular system. We tested the hypothesis whether endothelial cells respond to aldosterone with changes in cell volume, a measure for ion-mediated water movement across the cell membrane. By means of atomic force microscopy in fluid, we measured volume of adherent human umbilical venous endothelial cells exposed for 72 hours to 10 nmol/L aldosterone. Over this period of time, cells swell by approximately 18%. Aldosterone-induced swelling is prevented by 100 nmol/L of the mineralocorticoid receptor antagonist spironolactone, added to the primary endothelial cell culture. Aldosterone-treated cells dramatically shrink when 1 micromol/L of the diuretic amiloride is applied. Cells deprived of aldosterone do not respond to amiloride. Our conclusions are: (1) aldosterone leads to sustained cell swelling inhibited by administration of spironolactone or the sodium channel blocker amiloride; (2) cells respond to amiloride after aldosterone exposure; (3) renal diuretics act on endothelial cells; and (4) both amiloride and spironolactone could be useful for medical applications to prevent aldosterone-mediated endothelial dysfunction.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Amiloride,
http://linkedlifedata.com/resource/pubmed/chemical/Diuretics,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Mineralocorticoid,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium Channels,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium-Hydrogen Antiporter,
http://linkedlifedata.com/resource/pubmed/chemical/Spironolactone
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1524-4563
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
43
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
952-6
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:14993200-Aldosterone,
pubmed-meshheading:14993200-Aldosterone Antagonists,
pubmed-meshheading:14993200-Amiloride,
pubmed-meshheading:14993200-Biological Transport,
pubmed-meshheading:14993200-Body Water,
pubmed-meshheading:14993200-Cell Size,
pubmed-meshheading:14993200-Cells, Cultured,
pubmed-meshheading:14993200-Diuretics,
pubmed-meshheading:14993200-Endothelial Cells,
pubmed-meshheading:14993200-Endothelium, Vascular,
pubmed-meshheading:14993200-Humans,
pubmed-meshheading:14993200-Microscopy, Atomic Force,
pubmed-meshheading:14993200-Receptors, Mineralocorticoid,
pubmed-meshheading:14993200-Sodium,
pubmed-meshheading:14993200-Sodium Channels,
pubmed-meshheading:14993200-Sodium-Hydrogen Antiporter,
pubmed-meshheading:14993200-Spironolactone,
pubmed-meshheading:14993200-Umbilical Veins
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
Human endothelium: target for aldosterone.
|
| pubmed:affiliation |
Institute of Physiology II, Nanolab, University Münster, Germany. oberlei@uni-muenster.de
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|